Vanda Pharmaceuticals Inc (VNDA)
SG&A Expense Growth
5.09%
Quarterly · Period ending:
VNDA SG&A Expense Growth
Latest reported5.09%period ending
Latest reported5.09%period ending
VNDA Quarterly SG&A Growth (QoQ) (0.00% → 5.09%)
Latest values, visible window
High-resolution chart · PNG
VNDA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 5.0862% | |
| 8.5474% | |
| 4.4879% | |
| -6.7212% | |
| 29.0153% | |
| 27.4986% | |
| 4.5485% | |
| -4.8158% | |
| 31.2082% | |
| 27.4086% | |
| -4.6594% | |
| -12.7892% | |
| -21.3411% | |
| 10.1336% | |
| 9.8077% | |
| -9.5361% | |
| -19.2102% | |
| 22.1275% | |
| 3.0534% | |
| 14.4954% | |
| -4.8663% | |
| -16.2323% | |
| 4.6175% | |
| 0.2477% | |
| -8.3844% | |
| 0.0081% | |
| 22.491% | |
| -3.9628% | |
| 1.4148% | |
| 24.5045% | |
| -4.3191% | |
| -6.8419% | |
| 4.2428% | |
| -13.614% | |
| -0.241% | |
| -0.7874% | |
| 3.5449% | |
| 26.7286% | |
| 9.1245% | |
| -11.239% | |
| -15.7323% | |
| 1.4162% | |
| 56.4687% | |
| 0.3916% | |
| -2.2333% | |
| 8.5609% | |
| 53.4367% | |
| -59.8777% | |
| 0.8819% | |
| 183.1489% | |
| 72.4917% | |
| 12.5542% | |
| 28.1961% | |
| 22.7287% | |
| 2.4786% | |
| -12.6076% | |
| -7.8793% | |
| 16.861% | |
| 23.3862% | |
| 5.4044% | |
| -10.007% | |
| 3.4571% | |
| 34.5208% | |
| -27.7402% | |
| 14.1816% | |
| -73.0786% | |
| 75.5517% | |
| 5.5754% | |
| 18.0938% | |
| 3.148% | |
| -44.6625% | |
| -12.4746% | |
| -5.628% | |
| -5.4231% | |
| -1.8109% | |
| 29.5095% | |
| 19.5046% | |
| 39.5396% | |
| 36.8279% | |
| 9.5351% | |
| 1.9041% | |
| 61.6984% | |
| 8.6485% | |
| -10.6048% | |
| -9.5848% | |
| 0% |